This brand name is authorized in France, Tunisia, Turkey
The drug APRANAX contains one active pharmaceutical ingredient (API):
|
1
Naproxen
UNII 9TN87S3A3C - NAPROXEN SODIUM
|
|
Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M01AE02 | Naproxen | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 63738842, 67565882, 67849644 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9253111, 9253112, 9253113, 9253114, 9253115 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699514091509, 8699514091516, 8699514091523, 8699514091530 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
